Key result
In type 2 diabetic patients undergoing coronary CTA for chest pain, moderate to severe NAFLD was independently associated with significant coronary artery disease (P=0.04).
Why the study?
Is nonalcoholic fatty liver disease associated with significant coronary artery disease in type 2 diabetic patients?
Cross-Sectional (n=273)
Is nonalcoholic fatty liver disease associated with significant coronary artery disease in type 2 diabetic patients?
p-value: p=0.04
NAFLD is independently associated with significant coronary artery disease in type 2 diabetic patients, suggesting liver attenuation on CT can help identify high-risk individuals.
May support liver attenuation review on CTA in diabetic patients; leaves open prospective validation of NAFLD for CAD risk stratification.
BACKGROUND: To investigate whether nonalcoholic fatty liver disease (NAFLD) is associated with coronary artery disease (CAD) in type 2 diabetic patients, who underwent coronary computed tomography angiography (CTA). METHODS: Between June 2007 and May 2010, a total of 273 type 2 diabetic patients without known liver disease underwent coronary CTA for chest pain were enrolled. Axial, multiplanar, and Maximum intensity projection (MIP) images were used for determining the cardiovascular disease. Liver fat content was measured from unenhanced CT images obtained for calcium scoring. Moderate and severe NAFLD was defined when mean liver attenuation value is ≤40 Hounsfield Unit (HU). RESULTS: Among 273 patients, 76% of the patients (n = 207) had CAD; 48% of them had significant CAD (≥50 stenosis) by coronary CTA. Patients with CAD were older and male gender was predominant. Mean liver attenuation value calculated with CT was 50 ± 12 HU. Mean liver attenuation value was lower in patients with metabolic syndrome compared to patients without metabolic syndrome (P < 0.001). Moderate and severe NAFLD was observed in 22% of the patients (n = 59) with a mean attenuation value of 30 HU. After adjustment of age, gender, obesity, hypertension, smoking status and serum low-density lipoprotein (LDL) levels as coronary risk factors, NAFLD was associated with significant CAD (P = 0.04). CONCLUSIONS: In conclusion, the results of the present study indicate that NAFLD is associated with significant CAD in type 2 diabetic patients. Assessment of liver attenuation by CT represents noninvasive evaluation for detection of asymptomatic individuals with NAFLD during coronary CT angiography.
No takes yet. Share an insight, caveat, or question.
Idılman et al. (2014) conducted a cross-sectional in Type 2 diabetes with chest pain (n=273). Nonalcoholic fatty liver disease (NAFLD) vs. Without moderate/severe NAFLD was evaluated on Significant coronary artery disease (≥50% stenosis) (p=0.04). In type 2 diabetic patients undergoing coronary CTA for chest pain, moderate to severe NAFLD was independently associated with significant coronary artery disease (P=0.04).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: